Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Costa

Showing results (51-60 of 735) with videos related to

Pageof 74
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 1, 1993
Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous toneC Borghi, S Boschi, F V Costa, et al.
Archives of Biochemistry and Biophysics|February 1, 1993
Acquisition of ethanol tolerance in Saccharomyces cerevisiae: the key role of the mitochondrial superoxide dismutaseV Costa, E Reis, A Quintanilha, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657)F V Costa, C Borghi, S Boschi, et al.
Molecular Microbiology|February 1, 1996
The molecular defences against reactive oxygen species in yeastP Moradas-Ferreira, V Costa, P Piper, et al.
Clinical Therapeutics|January 1, 1985
Antihypertensive efficacy of two low dosages of hydrochlorothiazide in patients treated with captoprilF V Costa, C Borghi, A Mussi, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytesF V Costa, C Borghi, S Boschi, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exerciseF V Costa, C Borghi, A Mussi, et al.
American Journal of Hypertension|July 1, 1988
Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemiaF V Costa, C Borghi, A Mussi, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Factors associated with acute salt-sensitivity in borderline hypertensive patientsC Borghi, S Boschi, F V Costa, et al.
Osteoarthritis and Cartilage|May 25, 2002
Antisense oligonucleotides to the integrin receptor subunit alpha(5) decrease fibronectin fragment mediated cartilage chondrolysisG A Homandberg, V Costa, V Ummadi, et al.
Pageof 74

Showing results (51-60 of 735) with videos related to

Sort By:
Pageof 74
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 1, 1993
Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous toneC Borghi, S Boschi, F V Costa, et al.
Archives of Biochemistry and Biophysics|February 1, 1993
Acquisition of ethanol tolerance in Saccharomyces cerevisiae: the key role of the mitochondrial superoxide dismutaseV Costa, E Reis, A Quintanilha, et al.
International Journal of Clinical Pharmacology Research|January 1, 1984
Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657)F V Costa, C Borghi, S Boschi, et al.
Molecular Microbiology|February 1, 1996
The molecular defences against reactive oxygen species in yeastP Moradas-Ferreira, V Costa, P Piper, et al.
Clinical Therapeutics|January 1, 1985
Antihypertensive efficacy of two low dosages of hydrochlorothiazide in patients treated with captoprilF V Costa, C Borghi, A Mussi, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytesF V Costa, C Borghi, S Boschi, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exerciseF V Costa, C Borghi, A Mussi, et al.
American Journal of Hypertension|July 1, 1988
Use of captopril to reduce serum lipids in hypertensive patients with hyperlipidemiaF V Costa, C Borghi, A Mussi, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Factors associated with acute salt-sensitivity in borderline hypertensive patientsC Borghi, S Boschi, F V Costa, et al.
Osteoarthritis and Cartilage|May 25, 2002
Antisense oligonucleotides to the integrin receptor subunit alpha(5) decrease fibronectin fragment mediated cartilage chondrolysisG A Homandberg, V Costa, V Ummadi, et al.
Pageof 74